Category Finance

WIPO Survey On Patent Filing Strategies Shows Rise In Optimism

A recent economic survey by the World Intellectual Property Organization (WIPO) assessed the expected growth in domestic and international patent filings in 2010 compared to 2009. The highest expected growth rates were reported in Asian countries, with modest and declining growth reported in Europe and the United States respectively.

Innovation, Generic Drugs, Patents In Congress Follow Obama’s State of the Union Speech

American lawmakers aren’t wasting any time getting down to business after President Obama stressed the importance of spurring innovation during his annual State of the Union address this week and cited the need for the United States to regain its competitive edge, particularly when up against countries such as China and India. A slew of related bills are emerging in Congress.

Midem Music Congress: The Two Universes Of The Music Business

CANNES - More help from governments, a hope for new cloud music services and new markets in emerging countries like Brazil. India and China were on the wish list of the big music labels and publishers at this week's annual industry bash in Cannes, France. Technology companies and the newly invited hackers were more concerned with new ways to better access music and connecting artists and fans.

WHO Gears Up For Reform Driven By Financial Shortfall

The Executive Board session of the World Health Organization ended early on Monday after a week of discussions that settled some issues but left some others for the next governing meeting of the organisation in May, with much to do until then. The WHO is facing a significant gap in its budget and a programme of reforms is brewing.

The 2011 Drug Patent ‘Cliff’ And The Evolution Of IP Valuation

In today’s global economy, there is an increasing convergence of intellectual property and finance. Wall Street is grappling with how to recognise the true value of a firm’s intellectual property. Companies are realising that simply accumulating patents does not necessarily increase their firms’ value, but it is how those patents are used that can attract capital. And drug companies facing massive numbers of upcoming patent expiries, a deflated economy and other market pressures, are looking to diversify their portfolios to stay in the black.

Global Copyright Licensing Doubts And What To Do About Them

What do the fearsome leader of France’s three-strikes agency, a top Microsoft counsel, Google’s copyright counsel, a free software activist, Egyptian and British librarians, a South American development-oriented academic, and a European music authors’ representative have in common? While one might be tempted to say, ‘very little’, a recent gathering showed one thing - they represent the very wide range of current views on the future of copyright licensing.